Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Total 13F shares
-
136,760,070
-
Share change
-
+11,908,649
-
Total reported value
-
$1,710,429,850
-
Put/Call ratio
-
83%
-
Price per share
-
$12.51
-
Number of holders
-
178
-
Value change
-
+$152,914,470
-
Number of buys
-
101
-
Number of sells
-
65
Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q2 2015
As of 30 Jun 2015,
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) was held by
178 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
136,760,070 shares.
The largest 10 holders included
OPPENHEIMER FUNDS INC, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, FIRST TRUST ADVISORS LP, BlackRock Fund Advisors, STATE STREET CORP, Invesco Ltd., FEDERATED INVESTORS INC /PA/, BlackRock Institutional Trust Company, N.A., and GRANAHAN INVESTMENT MANAGEMENT INC/MA.
This page lists
174
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.